Mohadeseh Shafiei

Mohadeseh Shafiei

Auto-generated profile, based on publicly available information

Mohadeseh Shafiei

Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
YPYasamin Parvar
Yasamin Parvar
MAMaliheh Amani
Maliheh Amani
MSMohadeseh Shafiei
Mohadeseh Shafiei
FRFatemeh Rastaghi
Fatemeh Rastaghi
SHSeyed Ali Hosseini
Seyed Ali Hosseini
NANajmeh Ahramiyanpour
Najmeh Ahramiyanpour
Introduction: Skin pores are enlarged openings of the pilosebaceous follicles that can be affected by age, gender, genetics, exposure to UV light, ethnicity, and sebum secretion. Many treatment modalities reduce facial pores’ count and area, including oral and topical medications as well as different wavelengths of lasers. Finding a safe and cost‐effective treatment protocol is necessary since facial pores are one of the main reasons for cosmetic complaints.Aim: This review compares available treatment options for reducing facial pores’ number and area according to the published clinical trials.Methods: A search on PubMed and Google Scholar was performed. Nineteen published clinical trials regarding treatment options for facial pores were included and reviewed based on the authors’ clinical experience.Results: A total number of 591 cases (83.7% female) aged 18–80 years were included. Three assessment methods including digital imaging, physician assessment, and patient’ satisfaction were used in the studies to evaluate the therapeutic efficacy of each modality. Furthermore, combining different modalities increased the efficacy of reducing pores’ size and number. Mild, reversible burning and erythema were common side effects.Conclusion: Multiple sessions and combination therapies improve facial pores’ area and number. In young patients, the focus should be on controlling sebum production, while in older patients, the focus should be on rejuvenation in addition to the control of sebum production.

9 August 2022 in Clinical Case Reports
Verified
Journal Article
Open access
NSNasrin Saki
Nasrin Saki
FAFatemeh Sari Aslani
Fatemeh Sari Aslani
MSMozhdeh Sepaskhah
Mozhdeh Sepaskhah
MSMohadese Shafiei
Mohadese Shafiei
SASara Alavizadeh
Sara Alavizadeh
NANajmeh Ahramiyanpour
Najmeh Ahramiyanpour
Various conditions, including infections, can cause telogen effluvium (TE). One of them is coronavirus disease 2019 (COVID‐19), where hair loss usually begins between 2 and 12 weeks after the illness. TE can be acute or chronic, and the chronic type can be intermittent. Here, we present the case of a 17‐year‐old girl with severe and widespread hair loss following an upper respiratory infection suspected to be COVID‐19, with the patient having a history of such attacks since childhood. Evidence from biopsy and dermoscopy indicated a diagnosis of TE.

1 January 2024 in Sage Open Medicine
Verified
Journal Article
Open access
ASAli Sharifi
Ali Sharifi
AZAmin Zand
Amin Zand
MSMohadeseh Shafiei
Mohadeseh Shafiei
NNNaser Nasiri
Naser Nasiri
HSHamid Sharifi
Hamid Sharifi
MSMeraj Sharifi
Meraj Sharifi
Objectives: To assess the influence of age and gender on ocular biometric values and corneal astigmatism features in individuals undergoing phacoemulsification surgery and intraocular lens implantation. Methodology: This retrospective study measured ocular biometrics and corneal keratometric astigmatism using the IOLMaster 700 instrument prior to phacoemulsification surgery and intraocular lens implantation. Results: Analysis included ocular biometric and keratometric values from 3385 eyes of 3385 patients. Lens thickness ( p < 0.001, r = 0.387), mean keratometry ( p < 0.001, r = 0.156), and corneal astigmatism ( p < 0.001, r = 0.082) were positively correlated with age. Conversely, axial length ( p < 0.001, r = −0.133), anterior chamber depth ( p < 0.001, r = −0.244), and horizontal white-to-white corneal diameter ( p < 0.001, r = −0.226) exhibited negative correlations with age. Increasing age led to a significant shift towards against-the-rule astigmatism ( p < 0.001, r = 0.248). Mean keratometry was significantly lower in males than females ( p < 0.001). Axial length, anterior chamber depth, lens thickness, and white-to-white corneal diameter were higher in males compared to females (all ps ⩽ 0.001). Corneal astigmatism types differed significantly between genders ( p < 0.001), with against-the-rule being more prevalent among males (52.9%) and with-the-rule astigmatism having the highest prevalence among females (40.3%). Conclusions: Mean keratometry and lens thickness increased, while axial length and anterior chamber depth decreased with age. Males exhibited higher values for axial length, anterior chamber depth, and lens thickness, whereas females had steeper corneas.

3 October 2022 in Dermatologic Therapy
Verified
Journal Article
Closed access
NSNasrin Saki
Nasrin Saki
MAMaliheh Amani
Maliheh Amani
NNNazanin Zeinali Nezhad
Nazanin Zeinali Nezhad
ASAmirhossein Shahpar
Amirhossein Shahpar
MSMohadeseh Shafiei
Mohadeseh Shafiei
NANajmeh Ahramiyanpour
Najmeh Ahramiyanpour
Brimonidine is a vasoconstrictive agent used to treat several dermatologic disorders. Here, we review the uses of brimonidine in different aspects of dermatology. We searched keywords including rosacea, erythema, topical brimonidine, dermatology, and skin disease in PubMed, Cochrane, and Google Scholar to collect the related published articles. In a review of 15 articles, we found topical brimonidine improved the facial erythema of rosacea. In addition, it reduced the erythema associated with alcohol flushing syndrome, intense pulsed light therapy, and photodynamic therapy. Furthermore, topical brimonidine was used as a hemostatic agent in dermatosurgery procedures such as Mohs surgery and nail surgery to reduce intra-operative and postoperative bleeding. Some side effects such as erythema, flushing, and burning were reported in a few patients. Based on our findings, brimonidine is a beneficial drug that can be used in various dermatologic disorders with negligible side effects.

30 October 2023 in Middle East Journal of Digestive Diseases
Verified
Journal Article
Open access
PDF file
OEOmid Eslami
Omid Eslami
MNMohammad Javad Najafzadeh
Mohammad Javad Najafzadeh
MSMohadeseh Shafiei
Mohadeseh Shafiei
The Agreement between Endoscopic and Histopathological Findings of Esophageal and Gastroduodenal Lesions and Its Relationship with Endoscopists’ Experience